Outcomes in community-acquired Clostridium difficile infection

Alimentary Pharmacology and Therapeutics

Volumn 35, Issue 5, 2012, Pages 613-618

  Khanna, S ^a   Pardi, D S ^a   Aronson, S L ^b   Kammer, P P ^a   Baddour, L M ^a  

^a MAYO CLINIC   (United States)

^b DONALD AND BARBARA ZUCKER SCHOOL OF MEDICINE AT HOFSTRA NORTHWELL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METRONIDAZOLE; RIFAXIMIN; VANCOMYCIN;

ADULT; ARTICLE; CHARLSON COMORBIDITY INDEX SCORE; CLOSTRIDIUM DIFFICILE INFECTION; COMMUNITY ACQUIRED CLOSTRIDIUM DIFFICILE INFECTION; COMORBIDITY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HOSPITALIZATION; HUMAN; INFECTION COMPLICATION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POPULATION RESEARCH; PREDICTION; PRIORITY JOURNAL; RECURRENT DISEASE; SCORING SYSTEM; TREATMENT FAILURE; TREATMENT RESPONSE; UNITED STATES; UNSPECIFIED SIDE EFFECT;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; COMMUNITY-ACQUIRED INFECTIONS; EPIDEMIOLOGIC METHODS; FEMALE; HOSPITALIZATION; HUMANS; INFANT; MALE; MIDDLE AGED; MINNESOTA; REGRESSION ANALYSIS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84856712211     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2011.04984.x     Document Type: Article

References (29)

1. Jen MH, Saxena S, Bottle A, Aylin P, Pollok RC,. Increased health burden associated with Clostridium difficile diarrhoea in patients with inflammatory bowel disease. Aliment Pharmacol Ther 2011; 33: 1322-31.
2. Khanna S, Pardi DS, Aronson SL, et al,. The epidemiology of community-acquired Clostridium difficile infection: a population-based study. Am J Gastroenterol 2012; 107: 89-95.
3. Kelly CP, LaMont JT,. Clostridium difficile-more difficult than ever. N Engl J Med 2008; 359: 1932-40.
4. Kyne L, Hamel MB, Polavaram R, Kelly CP,. Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile. Clin Infect Dis 2002; 34: 346-53. (Pubitemid 34062235)
5. Centers for Disease C, Prevention. Severe Clostridium difficile-associated disease in populations previously at low risk-four states, 2005. MMWR Morb Mortal Wkly Rep 2005; 54: 1201-5.
6. Bauer MP, Goorhuis A, Koster T, et al,. Community-onset Clostridium difficile-associated diarrhoea not associated with antibiotic usage-two case reports with review of the changing epidemiology of Clostridium difficile-associated diarrhoea. Neth J Med 2008; 66: 207-11. (Pubitemid 351772002)
7. Wilcox MH, Mooney L, Bendall R, Settle CD, Fawley WN,. A case-control study of community-associated Clostridium difficile infection. J Antimicrob Chemother 2008; 62: 388-96. (Pubitemid 351984787)
8. Khanna S, Pardi DS,. The growing incidence and severity of Clostridium difficile infection in inpatient and outpatient settings. Expert Rev Gastroenterol Hepatol 2010; 4: 409-16.
9. Otten AM, Reid-Smith RJ, Fazil A, Weese JS,. Disease transmission model for community-associated Clostridium difficile infection. Epidemiol Infect 2010; 138: 907-14.
10. Ozaki E, Kato H, Kita H, et al,. Clostridium difficile colonization in healthy adults: transient colonization and correlation with enterococcal colonization. J Med Microbiol 2004; 53: 167-72. (Pubitemid 38223698)
11. Bavishi C, Dupont HL,. Systematic review: the use of proton pump inhibitors and increased susceptibility to enteric infection. Aliment Pharmacol Ther 2011; 34: 1269-81.
12. Fellmeth G, Yarlagadda S, Iyer S,. Epidemiology of community-onset Clostridium difficile infection in a community in the South of England. J Infect Public Health 2010; 3: 118-23.
13. Naggie S, Miller BA, Zuzak KB, et al,. A case-control study of community-associated Clostridium difficile infection: no role for proton pump inhibitors. Am J Med 2011; 124: 276.
14. St Sauver JL, Grossardt BR, Yawn BP, Melton LJ 3rd, Rocca WA,. Use of a medical records linkage system to enumerate a dynamic population over time: the Rochester epidemiology project. Am J Epidemiol 2011; 173: 1059-68.
15. Melton LJ 3rd,. History of the Rochester epidemiology project. Mayo Clin Proc 1996; 71: 266-74.
16. Charlson ME, Pompei P, Ales KL, MacKenzie CR,. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373-83. (Pubitemid 17055592)
17. McDonald LC, Coignard B, Dubberke E, Song X, Horan T, Kutty PK,. Recommendations for surveillance of Clostridium difficile-associated disease. Infect Control Hosp Epidemiol 2007; 28: 140-5. (Pubitemid 46374153)
18. Cohen SH, Gerding DN, Johnson S, et al,. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol 2010; 31: 431-55.
19. Ricciardi R, Rothenberger DA, Madoff RD, Baxter NN,. Increasing prevalence and severity of Clostridium difficile colitis in hospitalized patients in the United States. Arch Surg 2007; 142: 624-31. (Pubitemid 47080440)
20. Zilberberg MD, Shorr AF, Kollef MH,. Increase in Clostridium difficile-related hospitalizations among infants in the United States, 2000-2005. Pediatr Infect Dis J 2008; 27: 1111-3.
21. Zilberberg MD, Shorr AF, Kollef MH,. Increase in adult Clostridium difficile-related hospitalizations and case-fatality rate, United States, 2000-2005. Emerg Infect Dis 2008; 14: 929-31. (Pubitemid 351838602)
22. Centers for Disease Control and Prevention. Surveillance for community-associated Clostridium difficile-Connecticut, 2006. MMWR Morb Mortal Wkly Rep 2008; 57: 340-3.
23. Dubberke ER, Butler AM, Hota B, et al,. Multicenter study of the impact of community-onset Clostridium difficile infection on surveillance for C. difficile infection. Infect Control Hosp Epidemiol 2009; 30: 518-25.
24. Beaugerie L, Flahault A, Barbut F, et al,. Antibiotic-associated diarrhoea and Clostridium difficile in the community. Aliment Pharmacol Ther 2003; 17: 905-12. (Pubitemid 36459603)
25. Dubberke ER, Yan Y, Reske KA, et al,. Development and validation of a Clostridium difficile infection risk prediction model. Infect Control Hosp Epidemiol 2011; 32: 360-6.
26. Weese JS, Avery BP, Rousseau J, Reid-Smith RJ,. Detection and enumeration of Clostridium difficile spores in retail beef and pork. Appl Environ Microbiol 2009; 75: 5009-11.
27. Indra A, Lassnig H, Baliko N, et al,. Clostridium difficile: a new zoonotic agent? Wien Klin Wochenschr 2009; 121: 91-5.
28. Songer JG, Trinh HT, Killgore GE, Thompson AD, McDonald LC, Limbago BM,. Clostridium difficile in retail meat products, USA, 2007. Emerg Infect Dis 2009; 15: 819-21.
29. Weese JS, Reid-Smith RJ, Avery BP, Rousseau J,. Detection and characterization of Clostridium difficile in retail chicken. Lett Appl Microbiol 2010; 50: 362-5.